Benchmarks are brief communications that describe helpful hints, shortcuts, techniques or substantive modifications of existing methods.
Transposon mutagenesis is a commonly used method for identifying genes of interest in a bacterial genome because the insertion of a transposon into chromosomal or plasmid DNA often results in the disruption of a coding or regulatory region. However, identification and molecular analysis of the disrupted gene can often be difficult and time-consuming. We describe a simple and efficient protocol for the rapid identification and isolation of the transposon insertion site in the bacterial chromosome. This protocol is referred to as rapid amplification of transposon ends (RATE).
RATE combines methodologies such as the rapid amplification of cDNA ends (RACE) (1,2,5), solidphase DNA separation technology (3, 4) and DNA sequencing. Sequences at either or both ends of the transposon are used as templates in the design of specific oligonucleotide primers for the amplification by polymerase chain reaction (PCR) (9, 11, 14) of adjacent chromosomal DNA. The strategy used in the amplification and isolation of the adjacent unknown genomic DNA sequences of the transposon-mutated strains is described below and summarized in Figure 1 . Construction of the Neisseria meningitidis and Listeria monocytogenes transposon Tn 916 -mutated strains used in this study is described elsewhere (7, 8) . In the first step, chromosomal DNA is isolated from the transposon-mutated bacterial strain and 3-5 µ g digested with a restriction endonuclease. The restriction enzyme used must cleave at one or both termini of the transposon as near to the chromosomal junction as possible, while leaving the anchor primer sites intact. For our experiments, Sau 3AI proved to be the most convenient restriction enzyme. There are seven Sau 3AI sites within Tn 916 , two of which meet the criteria described above (near the transposon/chromosome junction) (Figure 1) . Restriction of the bacterial chromosome with Sau 3AI (New England Biolabs, Beverly, MA, USA) was performed following the manufacturer's recommendations. After digestion, the samples were phenol/chloroform-extracted, ethanol-precipitated and vacuum-desiccated using standard methods (15) . The DNA pellet was resuspended in 20 µ L of TE buffer (0.01 M Tris-HCl, 50 mM EDTA, pH 8.0) and 2 µ L of the appropriate linkers (250 µ M), 10 U of T4 DNA ligase (New England Biolabs) and 2.5 µ L of 10 ×T4 DNA ligase buffer added and the ligation reaction (final volume of 25 µ L) allowed to proceed for at least 3 h at room temperature or at 17°C overnight. The sequences of the linker primers (AUS1 and AUS2) used in this experiment are presented in Table 1 . The construction of this linker was performed as described by Utt et al. (19) . Unligated linkers were removed using Amicon ® Microcon ® 100 Microconcentrators (Millipore, Beverly, MA, USA) and the volume adjusted to 20-25 µ L with TE buffer. This step is very important because the presence of unligated linkers might interfere with subsequent steps, such as PCR amplification of the target fragment.
Unidirectional amplification of a single-stranded PCR product was performed using 5 ′ biotin-labeled primers specific for the known sequences of the right or left arm of the transposon, P1 and P2, respectively. Two to five microliters of the ligated mixture were subjected to 15 cycles of PCR (95°C for 1 min, 42°C for 1 min, 72°C for 1½ min in 25-µ L volumes) using a thermostable Taq DNA polymerase (Boehringer Mannheim, Indianapolis, IN, USA) following the manufacturer's recommendations. All amplification reactions were carried out with the Model 480 DNA Thermal Cycler (PE Applied Biosystems, Foster City, CA, USA). This reaction yields single-stranded DNA molecules containing sequences corresponding to the remaining portion of the transposon, the adjacent chromosomal DNA and the ligated linker. Unincorporated biotin-labeled oligonucleotides were removed using Micro -con 100 microconcentrators. Streptavidin-coated Dynabeads ® (Dynal AS, Oslo, Norway) were washed three times with a wash buffer (0.01 M TrisHCl, 0.001 M EDTA, pH 8.0 and 1 M NaCl) and used to capture the biotin-labeled single-stranded PCR products. Fifty microliters of streptavidin-coated beads (10 8 beads/mL) and 150 µ L of wash buffer were added to a microcentrifuge tube containing the biotin-labeled PCR product sample, mixed well and incubated at room temperature for 30 min with periodic mixing to prevent the beads from settling at the bottom of the tube. Next, the tubes were placed on a Magnetic Particle Concentrator (MPC ® ; Dynal AS). After 30 s, the supernatants were removed, and the bound PCR products and beads were washed three times with 100 µ L of wash buffer and once with 100 µ L of TE buffer and finally resuspended in 25 µ L of TE. The captured PCR products are recovered by boiling the samples for 5 min, immediately placing the tubes on the MPC and transferring the supernatants to fresh microcentrifuge tubes. Portions of the isolated products are then subjected to 25 cycles of PCR (94°C for 1 min, 42°C for 30 s, 72°C for 1½ min in 25-µ L volumes) using a nested primer specific for the transposon (P3 or P4) and a primer corresponding to the ligated linker (AUS2). Figure 2 shows the PCR-amplified fragments obtained from the captured single-stranded PCR products; a fragment of approximately 520 bp was obtained from the left arm (lane 2) and a 750-bp fragment from the right arm (lane 3). The PCR products were purified using Microcon 100 microconcentrators and can be sequenced directly. The identity of the fragments and the exact location of the transposon insertion were confirmed using a Model 373 Automated DNA Sequencer (PE Applied Biosystems) (Ribot, Raymond, Stephens and Quinn, unpublished).
However, if cloning is necessary, the transposon-specific and linker primers can be designed with unique sequences at their 5 ′ ends, such as restriction sites or other sequences to facilitate cloning of the PCR product into an appropriate vector system. In our experiments, cloning of PCR-amplified DNA fragments was performed using a modified version of the zipper cloning method described by Murtagh et al. (12) .
In our hands, this method has proven to be more efficient than single specific primer PCR (sspPCR) (6, 16) and present some advantages over other widely used techniques such as inverse PCR (18), partial inverse PCR (13) and thermal asymmetric interlaced PCR (10) . In sspPCR, a total genomic digest is ligated into a plasmid or vector followed by PCR using a vector-specif - Figure 1 . RATE strategy. The first step involves isolation of chromosomal DNA by the method of preference. We used the IsoQuick ® Nucleic Acid Extraction Kit (Orca Research, Bothell, WA, USA) (2). DNA was digested with a restriction endonuclease, Sau 3AI, followed by ligation of the AUS1-AUS2 linkers. Ligation mixture was subjected to unidrectional PCR amplification using a biotin-labeled, transposon-specific oligonucleotide primer. Target sequences for oligonucleotide primers P1 and P2 are located within left and right arms of the transposon, respectively, and are in close proximity to the transposon-chromosomal DNA junction. Resulting biotin-labeled, single-stranded PCR products were removed from other contaminants by extracting the samples using streptavidin-coated beads. Capture product was subjected to PCR amplification using both transposon-and linker-specific primers. Amplified products can then be sequenced directly. Locations of the relevant Sau 3AI restriction sites are indicated with an S. LA and RA represent the left and right arms of the transposon, respectively. Ln represents the AUS1-AUS2 linker. Oligonucleotide primers P3 and P4 are transposon-specific (nested to P1 and P2, respectively) primers used in conjunction with AUS2 for PCR amplification of the DNA fragments used for sequencing. Thick blocks represent double-stranded DNA. Thin blocks represent single-stranded DNA. The closed circle represents 5 ′ biotin moiety attached to oligonucleotide primers P1 and P2. ic primer and a target DNA-specific oligonucleotide. The fact that the template used in sspPCR contains a mixture of fragments representing the total genomic DNA often results in PCRs that yield many products that must be examined individually. Using RATE, rapid separation of the fragments of interest from the other contaminating DNA fragments is easily achieved by capturing the PCR-amplified, singlestranded, 5 ′biotin-labeled products with streptavidin-coated beads. In addition, initial isolation of the desired DNA fragments might be limited by the number of restriction sites present in the multiple cloning regions of the vectors commonly used in sspPCR. This often results in the ligation of DNA fragments that are too long to be PCRamplified using conventional methods. With RATE, one can design or use linkers based on restriction sites that are convenient or appropriate for the particular experiment.
We have used this method successfully for the identification and isolation of chromosomal DNA flanking the arms of Tn 916from N. meningitidis (Ribot, Raymond, Stephens and Quinn, unpublished) and L. monocytogenes (data not shown) mutant strains. The versatility of this technique will permit simple and rapid identification of transposon-mutated regions not only from prokaryotic but also from eukaryotic genomes.
Code Name
Oligonucleotide Sequence (5 ′→ ′→3 ′ ′ )
P4 c CTCGAAAGCACATAGAATAAGGC
B-denotes a biotin group at the 5 ′ end of the oligonucleotide. a AUS1 and AUS2 are the primers used to construct the linkers to be ligated onto the restricted genomic DNA. The use of this linker was first described by Straus and Ausubel (17) . AUS2 was also used in the amplification of the double-stranded PCR products. A modified version of these primers (19) was used in this experiment. b Transposon-specific oligonucleotide primers used for the PCR amplification of the DNA region upstream of the transposon insertion site. c Transposon-specific oligonucleotide primers used for PCR amplification of the unknown genomic sequence downstream of the transposon insertion site. With the rapid advances in tumor genetics, an increasing number of amplifications have been identified in various human neoplasms (4) . Examples of oncogenes amplified in tumors include N-mycand HER-2/ neu,which have been proposed as prognostic markers in neuroblastoma and breast cancer, respectively (5,7). To date, most of the information on the amplification of genes has been gathered from conventional Southern blot analysis, but this approach requires relatively large amounts of genomic DNA (5-10 µ g) and lacks sufficient sensitivity. Alternatively, comparative genomic hybridization has been used to detect and localize extended amplification domains in human cancers (3) . This method, however, is not tailored to the analysis of single loci.
Recently, quantitative polymerase chain reaction (PCR) application has gained increasing importance for the evaluation of oncogene amplification. Several modifications of this approach have been described, all of them bearing significant limitations. One of the widely used methods, called differential PCR, requires amplification of both a single-copy control gene and the gene of interest in the same vial (1). This in turn requires PCR conditions that are appropriate for both primer pairs in the same reaction. In addition, it remains unclear how an interaction of the two primers interferes with the amplification. To overcome these limitations, a method termed competitive PCR makes use of artificial internal standards that share the primer-binding sites with the gene of interest (6) . These standards, which are termed competitors, have to be synthesized and quantified for each gene separately.
According to most protocols, the determination of the gene amplification level also involves scintillation counting. We present a simple and rapid PCR scheme to assess gene amplification while avoiding time-intensive synthesis and use of competitors.
The method, which we termed comparative PCR, requires PCR amplification of a given gene in tumor DNA and normal DNA (most conveniently peripheral blood DNA). Because gene amplification is a hallmark of tumor DNA and is rarely found in normal human cells, it is not necessary to use a sample of blood DNA from each patient (9) . The signal intensity of the PCR products reflects the copy number of the gene in the tumor and peripheral blood DNA. By comparing the signals in tumor and normal DNA, the presence of gene amplification can be detected.
A necessary prerequisite for direct comparison of the band intensities in a stained agarose gel is the calibration of the system with a primer pair specific for a control gene not amplified in tumor DNA. Furthermore, the PCR amplification is to be performed on at least three different amounts of tumor and blood DNA. The implications of this step are threefold: (i) the three independent amplifications facilitate the assessment of the amplification status; (ii) they provide an internal control for the reproducibility of the experiment; and (iii) they serve as control to keep the PCR amplification within the exponential phase. A schematic representation of the experimental approach is given in Figure 1 . Details to this fast and 22BioTechniques
Vol. 24, No. 1 (1998) Figure 1 . Reaction scheme of the comparative PCR.
